| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $1,699,482 | -9,345 | -0.15% | $181.86 | 6,267,340 | 21 Jun 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $2,211,967 | -12,133 | -0.19% | $182.31 | 6,255,207 | 22 Jun 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.035 to $182.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.21 to $183.99. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |